1. Home
  2. DSL vs AMPH Comparison

DSL vs AMPH Comparison

Compare DSL & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DoubleLine Income Solutions Fund of Beneficial Interests

DSL

DoubleLine Income Solutions Fund of Beneficial Interests

HOLD

Current Price

$10.98

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$20.70

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DSL
AMPH
Founded
2013
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2013
2005

Fundamental Metrics

Financial Performance
Metric
DSL
AMPH
Price
$10.98
$20.70
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$29.29
AVG Volume (30 Days)
646.2K
453.3K
Earning Date
01-01-0001
05-06-2026
Dividend Yield
12.02%
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.03
Revenue
N/A
$719,887,000.00
Revenue This Year
N/A
$7.19
Revenue Next Year
N/A
$4.76
P/E Ratio
N/A
$10.05
Revenue Growth
N/A
N/A
52 Week Low
$10.49
$17.03
52 Week High
$12.67
$31.26

Technical Indicators

Market Signals
Indicator
DSL
AMPH
Relative Strength Index (RSI) 51.73 49.93
Support Level $10.89 $20.41
Resistance Level $11.45 $29.30
Average True Range (ATR) 0.15 0.68
MACD 0.05 0.42
Stochastic Oscillator 79.51 84.73

Price Performance

Historical Comparison
DSL
AMPH

About DSL DoubleLine Income Solutions Fund of Beneficial Interests

DoubleLine Income Solutions Fund is a closed-end management investment company. Its primary investment objective is to seek high income and its secondary objective is to seek capital appreciation. It invests in debt securities and other income-producing investments anywhere in the world, including emerging markets. The company's investment portfolio comprises foreign corporate bonds, U.S. corporate bonds, bank loans, collateralized loan obligations, non-agency commercial mortgage backed obligations, asset-backed obligations, and municipal bonds among others.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: